Jacobi Capital Management LLC Biogen Inc. Transaction History

Jacobi Capital Management LLC

$1.29 Billion
Q3 2024

A detailed history of Jacobi Capital Management LLC transactions in Biogen Inc. stock. As of the latest transaction made, Jacobi Capital Management LLC holds 2,815 shares of BIIB stock, worth $443,897. This represents 0.04% of its overall portfolio holdings.

Number of Shares

2,815

Previous 1,856 51.67%

Holding current value

$443,897

Previous $430,000 26.74%

% of portfolio

0.04%

Previous 0.04%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 14, 2024	BUY	$189.07 - $236.8 $181,318 - $227,091	959 Added 51.67%	2,815 $545,000
Q2 2024 Aug 09, 2024	BUY	$190.52 - $236.72 $36,579 - $45,450	192 Added 11.54%	1,856 $430,000
Q1 2024 May 10, 2024	BUY	$212.02 - $267.71 $11,661 - $14,724	55 Added 3.42%	1,664 $358,000
Q4 2023 Feb 14, 2024	SELL	$222.59 - $267.94 $44,518 - $53,588	-200 Reduced 11.06%	1,609 $416,000
Q3 2023 Nov 13, 2023	BUY	$253.3 - $285.89 $89,161 - $100,633	352 Added 24.16%	1,809 $464,000
Q4 2022 Feb 13, 2023	BUY	$252.44 - $306.72 $14,893 - $18,096	59 Added 4.22%	1,457 $403,000
Q3 2022 Nov 09, 2022	SELL	$194.69 - $268.46 $973 - $1,342	-5 Reduced 0.36%	1,398 $373,000
Q2 2022 Aug 05, 2022	SELL	$187.54 - $223.02 $34,507 - $41,035	-184 Reduced 11.59%	1,403 $286,000
Q2 2021 Aug 12, 2021	SELL	$259.0 - $414.71 $62,160 - $99,530	-240 Reduced 13.14%	1,587 $550,000
Q4 2020 Feb 08, 2021	SELL	$236.26 - $355.63 $7,796 - $11,735	-33 Reduced 1.77%	1,827 $447,000
Q2 2020 Aug 04, 2020	BUY	$258.66 - $342.55 $469,726 - $622,070	1,816 Added 4127.27%	1,860 $498,000
Q2 2020 Jul 27, 2020	SELL	$258.66 - $342.55 $458,862 - $607,683	-1,774 Reduced 97.58%	44 $498,000
Q1 2020 Apr 24, 2020	BUY	$268.85 - $341.04 $38,176 - $48,427	142 Added 8.47%	1,818 $575,000
Q4 2019 Feb 03, 2020	BUY	$220.06 - $304.07 $12,103 - $16,723	55 Added 3.39%	1,676 $497,000
Q3 2019 Nov 12, 2019	SELL	$217.44 - $243.88 $10,872 - $12,194	-50 Reduced 2.99%	1,621 $377,000
Q2 2019 Aug 07, 2019	SELL	$219.29 - $241.72 $2,192 - $2,417	-10 Reduced 0.59%	1,671 $391,000
Q1 2019 May 13, 2019	SELL	$216.71 - $338.96 $61,112 - $95,586	-282 Reduced 14.37%	1,681 $397,000
Q4 2018 Feb 11, 2019	SELL	$278.5 - $352.75 $87,170 - $110,410	-313 Reduced 13.75%	1,963 $591,000
Q3 2018 Nov 14, 2018	BUY	$293.51 - $383.83 $52,244 - $68,321	178 Added 8.48%	2,276 $804,000
Q2 2018 Aug 14, 2018	BUY	$257.52 - $306.91 $30,387 - $36,215	118 Added 5.96%	2,098 $609,000
Q1 2018 May 03, 2018	BUY	$260.13 - $367.91 $24,712 - $34,951	95 Added 5.04%	1,980 $528,000
Q4 2017 Feb 05, 2018	BUY	$307.64 - $344.58 $58,759 - $65,814	191 Added 11.28%	1,885 $621,000
Q3 2017 Nov 02, 2017	BUY	$281.15 - $329.69 $23,897 - $28,023	85 Added 5.28%	1,694 $557,000
Q2 2017 Aug 10, 2017	BUY	N/A	1,609	1,609 $440,000

Others Institutions Holding BIIB

# of Institutions

1,037

Shares Held

126M

Call Options Held

1.13M

Put Options Held

1.43M

View Full List

About BIOGEN INC.

Ticker BIIB
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 144,000,992
Market Cap $22.7B
Description
Biogen Inc. discovers, develops, manufactures, and delivers therapies for treating neurological and neurodegenerative diseases. The company offers TECFIDERA, VUMERITY, AVONEX, PLEGRIDY, TYSABRI, and FAMPYRA for multiple sclerosis (MS); SPINRAZA for spinal muscular atrophy; and FUMADERM to treat plaque psoriasis. It also provides BENEPALI, an eta...

More about BIIB

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Jacobi Capital Management LLC, based on Form 13F filings with the SEC.

News

Stay updated on Jacobi Capital Management LLC with notifications on news.

Account

Jacobi Capital Management LLC Biogen Inc. Transaction History